Clinical Trial Update: A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery [Phase 4]

View source ↗

Summary

A real-world Phase 4 study evaluating DEXYCU for inflammation after cataract surgery has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Inflammation

Drugs mentioned

• Dexycu (dexamethasone intraocular suspension)

Snippet

Sponsor: Ocumension Therapeutics (Shanghai) Co., Ltd | Conditions: Inflammation, Cataract | Phase 4 | Status: COMPLETED | Results posted: 2025-09-03